How OCT Imaging Detects Wet AMD Early
What Is Wet AMD?
Wet AMD is a serious eye condition that can threaten your central vision quickly. Understanding what it is and why early detection matters so much helps explain why we recommend regular OCT screening for anyone at risk.
Wet AMD occurs when abnormal, fragile blood vessels grow beneath the retina, the light-sensitive tissue at the back of the eye. These new blood vessels tend to leak fluid or blood into the macula, the small area of the retina responsible for sharp central vision. Even small amounts of leakage can damage the delicate cells you rely on for reading, driving, and recognizing faces.
Without treatment, wet AMD can cause severe central vision loss within weeks to months.
One of the most challenging aspects of wet AMD is that damage can begin before you notice anything is wrong. Tiny amounts of fluid may collect in or beneath the retina while your vision still feels normal. By the time you experience blurry or distorted vision, significant damage may have already occurred.
This is exactly why routine screening with advanced imaging is so valuable. Finding the disease at its earliest stage allows treatment to begin before irreversible harm is done.
Dry AMD is the more common form of macular degeneration. It involves the gradual thinning of the macula and the buildup of small deposits called drusen beneath the retina. Dry AMD usually progresses slowly over many years.
Wet AMD is less common but far more threatening to vision. It can develop suddenly when abnormal blood vessels begin to grow and leak. A person with dry AMD can convert to wet AMD at any time, which is why ongoing monitoring is so important for anyone already diagnosed with any form of macular degeneration.
How OCT Imaging Works
OCT is a non-invasive, painless imaging test that gives our specialists a remarkably detailed view of the retina. It is one of the most powerful diagnostic tools available in retina care today.
OCT stands for optical coherence tomography. The device sends safe infrared light beams into the eye and measures how they reflect back from each layer of retinal tissue. A computer assembles these measurements into precise cross-sectional images, similar to how an MRI creates images of the body, but using light instead of magnets. There is no radiation involved.
A standard eye exam or retinal photograph can only show the surface of the retina. OCT goes much deeper. It reveals all the individual layers of the retina in exceptional detail and can measure retinal thickness with extreme precision.
Most importantly, OCT can detect fluid that has accumulated between retinal layers. This fluid is one of the earliest signs of wet AMD. OCT shows it as dark, swollen spaces between normally tight retinal layers, even when the amount is too small to cause any noticeable change in vision.
An OCT scan is quick and completely comfortable. You sit in front of the machine, rest your chin on a support, and look at a small target while the device scans your eye with a beam of light. There are no flashes, no discomfort, and the scan itself does not require eye drops, though your pupils may be dilated beforehand to allow a more complete view.
The entire process typically takes only a few minutes, and your retina specialist can review the results with you right away.
Who Benefits Most from OCT Screening
While OCT is a valuable tool for many patients, certain individuals face a higher risk of developing wet AMD and have the most to gain from regular monitoring. Knowing whether you fall into a high-risk group is an important first step.
Several factors are associated with a greater likelihood of developing wet AMD. These include:
- Age 65 or older, with risk increasing significantly after age 85
- A diagnosis of dry AMD, especially with large drusen or changes to the retinal pigment epithelium (RPE), the tissue layer that supports the retina
- Advanced AMD already present in one eye
- A family history of macular degeneration
- Smoking, which is one of the most significant modifiable risk factors
If any of these apply to you, talk with one of our specialists about how often OCT screening makes sense for your situation.
People who have dry AMD in one eye are at particularly elevated risk for developing wet AMD in the other eye. Research has shown that among eyes with early subclinical macular neovascularization (abnormal blood vessel growth not yet causing symptoms), active leaking developed in a meaningful percentage of cases within a single year of follow-up. This makes OCT an especially critical monitoring tool for anyone who already carries a dry AMD diagnosis, even if their vision feels stable.
The right frequency of OCT screening depends on your individual risk level and the findings from previous exams. If you have been diagnosed with dry AMD, your retina specialist may recommend OCT scans every few months to watch for early signs of conversion to wet AMD. If you are at lower risk, annual screening during a dilated eye exam may be appropriate.
Your specialist will determine the schedule that gives you the best protection based on your specific findings.
How OCT Detects Wet AMD at the Earliest Stage
The real power of OCT lies in its ability to find wet AMD before it causes symptoms. Here is what our specialists are looking for when they review your scans.
One of the first signs of wet AMD is fluid building up in or beneath the retina. OCT can detect fluid at three different levels: intraretinal fluid (within the retinal layers), subretinal fluid (beneath the retina), and sub-RPE fluid (beneath the retinal pigment epithelium). Fluid at any of these levels can indicate active wet AMD. Because OCT is so sensitive, it can identify these changes weeks or even months before you would notice any difference in your vision.
OCT can also show the formation of choroidal neovascular membranes, which are the abnormal blood vessels responsible for wet AMD. These membranes appear as irregular thickening beneath the retina on OCT images. Identifying these structures early, sometimes before they have started to leak, gives our retina specialists a head start on planning treatment and helping to prevent vision loss.
OCT has a detection rate exceeding 95% for wet AMD, making it one of the most accurate diagnostic tools available for this condition.
One of the greatest strengths of OCT is its ability to compare scans from different visits. Our retina specialists can overlay your current scan with previous ones to measure even tiny changes in retinal thickness or spot new areas of fluid. This comparison helps determine whether your disease is stable, improving with treatment, or showing early signs of progression, and it directly guides decisions about your care.
What Happens After an Abnormal OCT Finding
When OCT reveals signs of wet AMD, our team moves quickly to confirm the diagnosis and begin protecting your vision. Here is what that process looks like.
If your OCT scan shows fluid or abnormal blood vessel growth, your retina specialist may order additional imaging to confirm the diagnosis and plan next steps. Fluorescein angiography uses a special dye to photograph blood flow in the retina and can identify exactly where vessels are leaking. OCT angiography, a newer technique that maps blood flow without dye, may also be used. Together, these tests give your specialist a complete picture of what is happening in your eye.
The primary treatment for wet AMD is anti-VEGF therapy. VEGF stands for vascular endothelial growth factor, a protein that stimulates the growth of abnormal blood vessels. Anti-VEGF medications are injected directly into the eye to block this protein, reduce leakage, and help stabilize or improve vision. Several options are currently available, including:
- Eylea (aflibercept), given every 4 to 8 weeks after an initial loading phase
- Eylea HD (high-dose aflibercept), approved for wet AMD and given monthly for 3 months followed by every 8 to 16 weeks
- Lucentis (ranibizumab), one of the first anti-VEGF medications approved for wet AMD, given every 4 weeks
- Avastin (bevacizumab), FDA-approved for cancer and used off-label for wet AMD, typically every 4 to 6 weeks
- Vabysmo (faricimab), a bispecific antibody that targets two pathways and can be given every 4 to 16 weeks
Your retina specialist will recommend the option that best fits your diagnosis and overall eye health.
Once treatment begins, OCT becomes the primary tool for monitoring how well the medication is working. Your specialist will perform OCT scans at each visit to check whether fluid has decreased, remained stable, or returned. Many retina specialists use a treat-and-extend approach, gradually increasing the time between injections as long as the wet AMD remains well-controlled. OCT scans guide these decisions and help find the longest safe interval between treatments while keeping the disease in check.
Advances in OCT and AMD Monitoring
Technology in retina care continues to advance, offering new ways to detect and manage wet AMD. Our team stays current with these developments so our patients benefit from the most up-to-date care available.
One exciting development in retina care is a home OCT monitoring system that allows patients with wet AMD to perform daily self-imaging at home. Scans are automatically uploaded and analyzed using deep learning algorithms, a form of artificial intelligence. This approach could allow for earlier detection of disease reactivation between office visits. Home OCT devices are currently being evaluated for broader clinical use, and our specialists will keep you informed as this technology develops.
Anti-VEGF therapy remains the standard of care for wet AMD, but the treatment landscape continues to evolve. The FDA has approved therapies for geographic atrophy, an advanced form of dry AMD, reflecting the rapid pace of retinal research that may yield additional options across all forms of AMD in the future. Our retina specialists, Dr. Gaurav Gupta and Dr. Pranjal Thakuria, stay actively engaged with advances in the field to ensure every patient receives care that reflects the current standard.
Living Well with a Wet AMD Diagnosis
A wet AMD diagnosis is a serious matter, but many patients successfully maintain meaningful vision for years with the right care and support. There is a great deal you can do between appointments to stay engaged in your own eye health.
Between appointments, using an Amsler grid can help you stay aware of changes in your central vision. An Amsler grid looks like graph paper with a dot in the center. By covering one eye at a time and looking at the dot, you can watch for wavy lines, missing areas, or blank spots. If you notice any of these changes, contact your retina specialist promptly. Home monitoring does not replace OCT scanning, but it serves as an important supplement between visits.
While treatment is essential for managing wet AMD, certain lifestyle habits may help support overall retinal health. Your specialist may recommend:
- Not smoking, as smoking significantly increases AMD risk and can speed progression
- Eating a diet rich in leafy greens, fish, and colorful fruits and vegetables
- Maintaining a healthy weight and staying physically active
- Wearing sunglasses that block ultraviolet light
- Taking AREDS2 nutritional supplements if recommended by your retina specialist
These choices support your treatment, though they are not a substitute for it.
A wet AMD diagnosis can feel overwhelming, and it is completely normal to have concerns about your vision and your daily life. Many patients find it helpful to connect with low-vision rehabilitation services, support groups, or counseling. Our team can connect you with resources to help you adapt to any vision changes and maintain your quality of life.
When to See a Retina Specialist
Knowing when to act quickly can make a meaningful difference in your outcomes. There are certain symptoms that should not wait, and there are also situations where routine screening should be scheduled proactively.
The following symptoms may indicate a serious problem with the retina and should be evaluated by a retina specialist as soon as possible:
- A sudden increase in floaters (spots or threads drifting in your vision)
- Flashes of light
- A curtain or shadow appearing over part of your vision
- Sudden vision loss in one eye
- New wavy or distorted vision, especially straight lines appearing bent
- A dark or blank spot appearing in the center of your vision
Do not wait for a scheduled appointment if you experience any of these symptoms. Contact us right away or go to the nearest emergency eye care facility.
Even without symptoms, regular eye exams that include OCT imaging are essential if you are at risk for wet AMD. Our optometry team and ophthalmologists can screen for early signs of AMD and refer you to one of our retina specialists if anything needs a closer look. If you are over 65, have a family history of AMD, or have already been diagnosed with dry AMD, ask about adding OCT to your routine exam schedule.
Frequently Asked Questions
These answers address common questions patients ask about OCT imaging and wet AMD care. They are intended to add practical guidance to what is already covered above.
OCT uses infrared light, not radiation, and never makes contact with your eye. There is no known limit on how often an OCT scan can be performed safely. During active treatment for wet AMD, your specialist may order scans at every visit, sometimes as frequently as every four weeks. The test can be repeated as many times as clinically needed without any risk to your eyes or general health.
Yes, and this is one of the most important reasons we recommend OCT for at-risk patients. The test can reveal tiny amounts of fluid beneath the retinal layers or early abnormal blood vessel growth long before these changes affect your vision. Catching wet AMD at this pre-symptomatic stage means treatment can begin before meaningful vision loss occurs, which gives you the best chance of protecting your central vision long-term.
A standard eye exam gives your eye care provider a view of the surface of the retina. OCT creates detailed cross-sectional images of all the layers beneath that surface, making it possible to measure retinal thickness precisely and detect fluid or structural changes that would be completely invisible during a traditional examination. Both types of exams play an important role, but OCT provides information that no other routine test can match when it comes to wet AMD detection and monitoring.
In most cases, yes. When OCT shows active fluid from abnormal blood vessels, prompt treatment with anti-VEGF injections is typically recommended to stop further damage. Treatment usually begins with a loading phase of monthly injections over the first few months. Starting treatment early, before significant vision loss occurs, gives you the best opportunity to maintain your current level of vision. Your retina specialist will build a personalized plan based on your specific OCT findings and overall eye health, and that plan will continue to be adjusted as your condition responds to treatment.
Wet AMD is a chronic condition, and ongoing monitoring is a standard part of care for most patients. OCT remains the primary tool used for this monitoring. Even if your condition appears stable, periodic scans are generally recommended because wet AMD can reactivate after quiet periods. Over time, if the disease remains well-controlled, the frequency of scans may decrease, but lifelong monitoring is the current standard approach. Your retina specialist will explain what an appropriate long-term schedule looks like for your situation.
Contact your retina specialist right away. New distortion, such as straight lines appearing wavy or bent, is one of the warning signs that wet AMD may be activating or progressing. Do not wait until your next scheduled visit. Prompt evaluation with OCT can determine whether fluid has returned or increased, and treatment can be adjusted quickly if needed. Acting fast when you notice a change gives your specialist the best opportunity to protect your vision before further damage occurs.
Protecting Your Vision Starts Here
At Rhode Island Eye Institute, our fellowship-trained retina specialists, Dr. Gaurav Gupta and Dr. Pranjal Thakuria, bring advanced expertise and state-of-the-art OCT technology to every patient who walks through our doors. We are proud to serve patients across Rhode Island with compassionate, subspecialty-level retina care under one roof. If you are at risk for wet AMD or have already been diagnosed, we encourage you to schedule an appointment so we can help you protect the vision that matters most to you.